ELIZABETH NG

Chief Executive Officer

MBA, Stanford
BS Physics, MIT

VP Strategy and Business Development, Bioelectric Devices

Sr. Director Portfolio Strategy, BioMarin

Director Strategy Development Group, Merck

Director Commercial Strategy, Gilead
Sr. Director Engagement Manager, Strategic Decisions Group

Executive with extensive experience in strategy and portfolio/pipeline optimization. Knowledgeable about pharmaceutical/biotech company operations.

Broad leadership of cross-functional executive teams.

Expertise across multiple therapeutic areas with
focus on oncology, anti-infectives, orphan diseases.